Back

Histidine triad nucleotide-binding protein 2 deficiency induce myocardial glucose utilization disorder in mice

26 August 2023 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Pathophysiology of heart failure: basic mechanisms Pathophysiology ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Mengkang Fan

Affiliated Hospital of Nantong University, Nantong (China)

7 More presentations in this session

Presentation thumbnail
Genome-wide association study of heart failure in a multiethnic south-east asian cohort
Mr S. Loong (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
IkBz is an inhibitor of the serine/threonine kinase and liquid-liquid phase separation that causes transition from adaptive cardiac hypertrophy to heart failure during pressure overload
Assistant Professor Y. Tanaka (Aichi, JP)
Abstract Slides Video
Presentation thumbnail
Increased clonal hematopoiesis mutational burden and accelerated dynamic evolution of circulating clones in patients with ischemic heart failure.
Doctor K. Kirschbaum (Frankfurt, DE)
Abstract Slides Video
Presentation thumbnail
Modeling cardiac injury using human cardiac slices to test therapeutic approaches for cardiac regeneration and repair
Doctor A. Lodrini (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Role of beta-3 adrenergic receptor polymorphism TRY64ARG in heart failure.
Doctor G. Jimenez Rodriguez (Ciudad de Mexico, MX)
Abstract Slides Video

Access the full session

Session thumbnail
Pathophysiology of heart failure: basic mechanisms

The Event

Event poster

ESC Congress 2023

26 August 2023 10:15 CET
You may be interested in
thumbnail
Congress Session
Metabolic reprogramming and crosstalk in cardiometabolic and vascular disease
thumbnail
Congress Presentation
Sodium-glucose cotransporter 2 inhibitors alter cardiac glucose transporter expression in patients with heart failure
thumbnail
Congress Presentation
ACEI plus GLP1-RA or SGLT2i, as well as ARNI, exerted distinct protective effects against diabetic nephropathy and heart failure with preserved ejection fraction in eNOS-/- dbdb mice.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources